Mendus AB (OSTO:IMMU) Other Financing : kr-4.65 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Other Financing?

Mendus AB's Other Financing for the three months ended in Dec. 2024 was kr0.00 Mil.

Mendus AB's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was kr-4.65 Mil.

Mendus AB Other Financing Historical Data

The historical data trend for Mendus AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Other Financing Chart

Mendus AB Annual Data

Trend

Jun15

Jun16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Financing

Get a 7-Day Free Trial

-2.05

-12.29

-23.89

-4.65

Mendus AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Financing	Get a 7-Day Free Trial															-10.42	-	-4.61	-0.05	-

Mendus AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-4.65 Mil.

Mendus AB Other Financing Related Terms

Thank you for viewing the detailed overview of Mendus AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Mendus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

1YG0:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, 11153

Website

https://www.mendus.com

Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.